BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18569231)

  • 21. The effect of polymorphism of the beta-2 adrenergic receptor on the response to beta-2 agonist in bronchial asthma patients.
    Syamsu ; Yusuf I; Budu ; Patellongi I
    Acta Med Indones; 2007; 39(1):8-12. PubMed ID: 17297203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma.
    Hancox RJ; Sears MR; Taylor DR
    Eur Respir J; 1998 Mar; 11(3):589-93. PubMed ID: 9596107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
    Chung LP; Waterer G; Thompson PJ
    Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADRB2 polymorphisms and asthma susceptibility: transmission disequilibrium test and meta-analysis.
    Migita O; Noguchi E; Jian Z; Shibasaki M; Migita T; Ichikawa K; Matsui A; Arinami T
    Int Arch Allergy Immunol; 2004 Jun; 134(2):150-7. PubMed ID: 15153795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
    Carroll CL; Stoltz P; Schramm CM; Zucker AR
    Chest; 2009 May; 135(5):1186-1192. PubMed ID: 19029431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27.
    Lee DK; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jan; 57(1):100-4. PubMed ID: 14678347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of polymorphism of human beta 2-adrenergic receptor gene and bronchial asthma].
    Gao JM; Lin YG; Qiu CC; Gao J; Ma Y; Liu YW; Liu Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):626-31. PubMed ID: 12905693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
    Metzger NL; Kockler DR; Gravatt LA
    Ann Pharmacother; 2008 Jun; 42(6):874-81. PubMed ID: 18430791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetic tests in asthma therapy.
    Yu IW; Bukaveckas BL
    Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response.
    Park HW; Yang MS; Park CS; Kim TB; Moon HB; Min KU; Kim YY; Cho SH
    Allergy; 2009 May; 64(5):778-83. PubMed ID: 19183167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The functional relevance of Arg16Gly and Gln27Glu-beta2-adrenoreceptor polymorphism in patients with asthma and allergic rhinitis].
    Cichy M; Adamek-Guzik T; Uracz D; Uracz W; Czerniawska-Mysik G; Korbut R; Guzik TJ
    Folia Med Cracov; 2005; 46(1-2):33-51. PubMed ID: 17037286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic acidosis, respiratory distress, and children with severe acute asthma.
    Ramnarayan P; Chhabra R; Maheshwari P
    Pediatr Crit Care Med; 2009 Jan; 10(1):142-3; author reply 143. PubMed ID: 19131879
    [No Abstract]   [Full Text] [Related]  

  • 33. ALOX5 promoter genotype, asthma severity and LTC production by eosinophils.
    Kalayci O; Birben E; Sackesen C; Keskin O; Tahan F; Wechsler ME; Civelek E; Soyer OU; Adalioglu G; Tuncer A; Israel E; Lilly C
    Allergy; 2006 Jan; 61(1):97-103. PubMed ID: 16364163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-2 adrenergic receptor genetic polymorphisms and asthma.
    Hizawa N
    J Clin Pharm Ther; 2009 Dec; 34(6):631-43. PubMed ID: 20175796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment.
    Contopoulos-Ioannidis DG; Alexiou GA; Gouvias TC; Ioannidis JP
    Pharmacogenet Genomics; 2006 Oct; 16(10):705-11. PubMed ID: 17001289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of long-acting beta2-agonists in the treatment of asthma.
    Cazzola M; Matera MG
    Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do children with acute asthma benefit more from anticholinergics and beta2 agonists than from beta2 agonists alone?
    Cleary-Hammarstedt C; Flynn CA
    Am Fam Physician; 2002 Aug; 66(3):417-8. PubMed ID: 12182517
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta 2 adrenergic receptor polymorphisms in cystic fibrosis.
    Hart MA; Konstan MW; Darrah RJ; Schluchter MD; Storfer-Isser A; Xue L; Londono D; Goddard KA; Drumm ML
    Pediatr Pulmonol; 2005 Jun; 39(6):544-50. PubMed ID: 15806595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between beta-adrenoceptor gene polymorphisms and relative response to beta 2-agonists and anticholinergic drugs in Japanese asthmatic patients.
    Asano K; Yamada-Yamasawa W; Kudoh H; Matsuzaki T; Nakajima T; Hakuno H; Hiraoka R; Fukunaga K; Oguma T; Sayama K; Yamaguchi K; Nagabukuro A; Harada Y; Ishizaka A
    Respirology; 2010 Jul; 15(5):849-54. PubMed ID: 20546196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene.
    Cho SH; Oh SY; Bahn JW; Choi JY; Chang YS; Kim YK; Min KU; Kim YY
    Clin Exp Allergy; 2005 Sep; 35(9):1162-7. PubMed ID: 16164442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.